LIVE

Serial Number

86355377

Owner

Sage Therapeutics, Inc.

Attorney

Steven A. Abreu

Filing Date

Aug 1, 2014

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

SAGE THERAPEUTICS Trademark

Serial Number: 86355377 • Registration: 4879416

SAGE THERAPEUTICS is a trademark filed by Sage Therapeutics, Inc. on August 1, 2014. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Trademark Classes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Sage Therapeutics, Inc. (42 trademarks)

215 First Street
Cambridge, MA 02142

Entity Type: 03

Legal Representation

Attorney of Record

Steven A. Abreu

1,781 trademarks filed View all →

Correspondence Address

Steven A. Abreu Sunstein LLP

100 High Street

Boston, MA 02110

United States

Trademark Details

Filing Date

August 1, 2014

Registration Date

January 5, 2016

Published for Opposition

July 14, 2015

Goods & Services

Pharmaceutical research and development services, namely, research and development of pharmaceuticals to treat central nervous system disorders

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Jan 5, 2025 REM2

SEC. 15 ACKNOWLEDGEMENT - E-MAILED

Nov 1, 2024 NA15

REGISTERED - SEC. 15 ACKNOWLEDGED

Nov 1, 2024 15AK

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Nov 1, 2024 APRE

TEAS SECTION 15 RECEIVED

Jul 22, 2024 E15R

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Dec 23, 2022 NAS8

REGISTERED - SEC. 8 (6-YR) ACCEPTED

Dec 23, 2022 8.OK

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Dec 23, 2022 APRE

TEAS SECTION 8 RECEIVED

Jul 1, 2022 ES8R

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Jan 5, 2021 REM1

COUNTERCLAIM OPP. NO. 999999

Nov 4, 2020 CCON

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Feb 10, 2020 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Apr 27, 2018 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Apr 27, 2018 REAP

REGISTERED-PRINCIPAL REGISTER

Jan 5, 2016 R.PR

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

Nov 27, 2015 ETOP

EXTENSION OF TIME TO OPPOSE RECEIVED

Aug 13, 2015 ETOF

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 14, 2015 NPUB

PUBLISHED FOR OPPOSITION

Jul 14, 2015 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 24, 2015 NONP

LAW OFFICE PUBLICATION REVIEW COMPLETED

Jun 10, 2015 PREV

ASSIGNED TO LIE

Jun 10, 2015 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

May 20, 2015 CNSA

ASSIGNED TO EXAMINER

Apr 28, 2015 DOCK

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 8, 2015 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 7, 2015 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 7, 2015 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 22, 2014 GNRN

NON-FINAL ACTION E-MAILED

Nov 22, 2014 GNRT

NON-FINAL ACTION WRITTEN

Nov 22, 2014 CNRT

ASSIGNED TO EXAMINER

Nov 15, 2014 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Aug 12, 2014 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 11, 2014 NWOS

NEW APPLICATION ENTERED

Aug 5, 2014 NWAP

Related Trademarks

More from this Owner

SAGE THERAPEUTICS

Serial #98915590

More in Same Class

MYNDAR

DEUTSCHE TELEKOM INFINITE M2M SIM

INFERNORED TECHNOLOGY

MYNDAR

VERIDOS IDENTITY SOLUTIONS BY GIESECKE & DEVRIENT AND BUNDESDRUCKEREI

MOVEMENT OF LIFE